US 8,618,059 B2Granted

Methods for treating reperfusion injuries using flagellin

AssigneesCleveland BioLabs, Inc., The Cleveland Clinic Foundation

InventorsAndrei Gudkov, Robert Fairchild

Life of this patent

Estimating the term…

Abstract

The present invention relates to treating a tissue in a mammal from the effects of reperfusion using flagellin.

Claims11

Dependent claims

A method of treating a tissue of a mammal for the effects of reperfusion comprising administering to a mammal in need thereof a composition comprising flagellin, wherein the flagellin comprises the sequence of SEQ ID NO:

Dependencies are inferred from the claim text.

Facts

Application: 13/530,580Filed 22 Jun 2012 · continuation
Priority: 1 Aug 2008
Published: US 2013/0004515 A13 Jan 2013
Granted: 31 Dec 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 38/164
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from bacteria
A61K 31/355
3,4-Dihydrobenzopyrans, e.g. chroman, catechin: tocopherols, e.g. vitamin E
A61K 31/661
Phosphorus compounds: phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…

Family

Application61/085,766Us provisional application · filed 1 Aug 2008
PCT/US2009/052493Parent of this continuation · filed 31 Jul 2009
US 2013/0004515 A1Pre-grant publication · published 3 Jan 2013
Application13/056,973Parent of this continuation
US 8,324,163 B2Parent of this continuation
US 2011/0135665 A1Published application
US 8,618,059 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Facts

Application

13/530,580Filed 22 Jun 2012 · continuation

Priority

1 Aug 2008

Published

US 2013/0004515 A13 Jan 2013

Granted

31 Dec 2013

Term ends

Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 38/164
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from bacteria
A61K 31/355
3,4-Dihydrobenzopyrans, e.g. chroman, catechin: tocopherols, e.g. vitamin E
A61K 31/661
Phosphorus compounds: phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…

Family

Application61/085,766Us provisional application · filed 1 Aug 2008

PCT/US2009/052493Parent of this continuation · filed 31 Jul 2009

US 2013/0004515 A1Pre-grant publication · published 3 Jan 2013

Application13/056,973Parent of this continuation

US 8,324,163 B2Parent of this continuation

US 2011/0135665 A1Published application

US 8,618,059 B2This patent

From the US filing history. Foreign family members aren’t listed.